GSA Capital Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54,545
Closed -$391K 2043
2025
Q4
$391K Sell
54,545
-41,267
-43% -$326K 0.03% 981
2025
Q3
$1.02M Sell
95,812
-93,421
-49% -$917K 0.09% 382
2025
Q2
$1.83M Buy
+189,233
New +$1.95M 0.13% 149
2025
Q1
Sell
-57,517
Closed -$858K 1957
2024
Q4
$858K Buy
+57,517
New +$937K 0.06% 508
2024
Q1
Sell
-24,088
Closed -$347K 1869
2023
Q4
$347K Buy
+24,088
New +$328K 0.03% 1031
2022
Q4
Sell
-20,827
Closed -$487K 1765
2022
Q3
$487K Buy
+20,827
New +$629K 0.06% 586

Other funds holding OGN

GSA Capital Partners's OGN Position: Q1 2026 in Review

GSA Capital Partners sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 54,545 shares — an estimated $391K sold.

GSA Capital Partners first reported a position in OGN in Q3 2022 and held it in 6 quarters. The position peaked at $1.83M in Q2 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • GSA Capital Partners reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 54,545 Organon & Co shares in Q1 2026, an estimated $391K.
  • GSA Capital Partners first reported a position in Organon & Co in Q3 2022 and held it in 6 quarters.
  • GSA Capital Partners's Organon & Co position peaked at $1.83M in Q2 2025.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.